Marianne Z. Metz

Medicine · Health Sciences

23h-index2.0kcitations53works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(19), Neuroblastoma Research and Treatments(16), Pluripotent Stem Cells Research(11), Neurogenesis and neuroplasticity mechanisms(7), Cancer, Hypoxia, and Metabolism(6)

Publications53 total

Supplementary Figure S1 from Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia
2023Open Access
Supplementary Figure S1 from Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia
2023Open Access
Data from Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia
2023Open Access
Data from Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia
2023Open Access
Data from Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
2023Open Access
Supplementary Tables 1 and 2 from Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
2023Open Access
Supplementary Methods from Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
2023Open Access
Data from Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
2023Open Access
Supplementary Methods from Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
2023Open Access
Supplementary Tables 1 and 2 from Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
2023Open Access
Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients
Cancer Gene Therapy·2020· 18 citedOpen Access
Quantitative Evaluation of Intraventricular Delivery of Therapeutic Neural Stem Cells to Orthotopic Glioma
Frontiers in Oncology·2019· 38 citedOpen Access
ACTR-22. A PHASE I STUDY OF CYTOSINE DEAMINASE-EXPRESSING NEURAL STEM CELLS (CD-NSCs) ADMINISTERED INTRACRANIALLY AND IN COMBINATION WITH ORAL 5-FLUOROCYTOSINE (5-FC) AND LEUCOVORIN IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
Neuro-Oncology·2018Open Access
GMP Production and Scale-Up of Adherent Neural Stem Cells with a Quantum Cell Expansion System
Molecular Therapy — Methods & Clinical Development·2018· 32 citedOpen Access
STEM-32. PRE-CLINICAL SAFETY AND EFFICACY STUDIES OF NEURAL STEM CELL MEDIATED CARBOXYLESTERASE/IRINOTECAN ENZYME/PRODRUG GENE THERAPY FOR RECURRENT GLIOMA LEADING TO FIRST-IN-HUMAN PHASE I CLINICAL TRIAL
Neuro-Oncology·2017Open Access
Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model
Stem Cells Translational Medicine·2017· 29 citedOpen Access
Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
Clinical Cancer Research·2016· 155 citedOpen Access
Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma
Molecular Therapy — Oncolytics·2016· 24 citedOpen Access
STEM-01NEURAL STEM CELL-MEDIATED ENZYME/PRODRUG THERAPY FOR NEUROBLASTOMA: TRANSLATION TO THE CLINIC
Neuro-Oncology·2015Open Access
20. Carboxylesterase-Secreting Neural Stem Cells Increase Efficacy of Irinotecan in Orthotopic Glioma Models: Translation Toward the Clinic
Molecular Therapy·2015Open Access
page 1 of 3Next →

Frequent Co-authors

Karen S. Aboody(37), Margarita Gutova(29), Joseph Najbauer(26), Revathiswari Tirughana(16), Timothy W. Synold(15), Seung Up Kim(15), Jana Portnow(13), Carlotta A. Glackin(13), Massimo D’Apuzzo(11), Michael E. Barish(11), Rex Moats(10), Behnam Badie(10), Stephen E. Kendall(9), Elizabeth Garcia(8), Alexander J. Annala(7), R.T. Frank(7), Simon F. Lacey(7), Tien Vo(7), Elizabeth Garcia(7), Susan E. Kane(7)